BioCentury
ARTICLE | Company News

Geaney leaves as Elan CEO

July 9, 2002 7:00 AM UTC

Donal Geaney has departed as chairman and CEO of ELN and Thomas Lynch departed as vice chairman. Garo Armen, chairman and CEO of Antigenics (AGEN) and an ELN director, has been appointed chairman of the board and of a five-person executive committee that will have "broad authority over the management of Elan on an interim basis" until a new CEO is named.

Other members of the executive committee include: Laurence Crowley, chairman of the Bank of Ireland and chairman of PJ Carroll; Ann Gray, former president of Diversified Publishing Group of Capital Cities/ABC; Kyran McLaughlin, former head of equities and corporate finance of Davy Stockbrokers; and Daniel Tully, chairman emeritus of Merrill Lynch. ...